Marin O, Meggio F, Sarno S, Andretta M, Pinna L A
Dipartimento di Chimica Biologica, Università di Padova, Italy.
Eur J Biochem. 1994 Jul 15;223(2):647-53. doi: 10.1111/j.1432-1033.1994.tb19037.x.
The major phosphorylation site for both casein kinase-2 (CK2) and casein kinase-1 (CK1) in protein phosphatase-1 (PP-1) inhibitor-2 (I-2) is Ser86. Minor phosphorylation sites affected by either CK2 or CK1 are Ser120/Ser121 and Ser174, respectively. A synthetic peptide of 25 amino acids encompassing residues 67-93 of I-2 is phosphorylated by either CK2 or CK1 at its seryl residue corresponding to Ser86 with higher Vmax and Km values similar to those of the intact protein (9 vs 7.2 microM and 14.2 vs 5.3 microM with CK2 and CK1, respectively). No detectable phosphorylation of this peptide which also includes the glycogen synthase kinase-3 (GSK-3) site (Thr72), could be observed with either GSK-3 or p34cdc2 kinase whether or not its seryl residue equivalent to Ser86 had been previously phosphorylated by CK2. Shorter derivatives of I-2(67-93), encompassing residues 72-93 and 78-93, are also readily phosphorylated by both CK1 and CK2, with phosphorylation efficiencies similar to those of the parent peptide. A synthetic heptadecapeptide reproducing the phosphoacceptor site around Ser120/Ser121 is phosphorylated by CK2, but not to any detectable extent by CK1, with a Km value fivefold higher than that of the corresponding pentadecapeptide including Ser86 (78-93). A synthetic pentadecapeptide (166-180) reproducing the phosphoacceptor site around Ser174 is phosphorylated by CK1 less efficiently than the pentadecapeptide including its main phosphorylation site (78-93) (Km 280 microM vs 33 microM). This peptide is readily phosphorylated by CK2 as well, although it lacks the canonical consensus sequence for CK2 and its Ser174 is almost unaffected by CK2 in intact I-2. These data provide the clear-cut demonstration that the consensus sequence with N-terminal prephosphorylated residue(s), SerP/ThrP-Xaa-Xaa-Ser/Thr, [Flotow, H., Graves, P. R., Wang, A., Fiol, C. J., Roeske, R. W. & Roach, P. J. (1990) J. Biol. Chem. 265, 14264-14269; Meggio, F., Perich, J. W., Reynolds, E. C. & Pinna, L. A. (1991) FEBS Lett. 283, 303-306] is not always required to achieve efficient and high-affinity phosphorylation by CK1. They also show that the specificity determinants for I-2 phosphorylation by either CK2 or CK1, but not by GSK3, are entirely grounded on local structural features of the phosphoacceptor site, being only marginally affected by the overall structure of I-2.
蛋白磷酸酶-1(PP-1)抑制剂-2(I-2)中酪蛋白激酶2(CK2)和酪蛋白激酶1(CK1)的主要磷酸化位点是Ser86。受CK2或CK1影响的次要磷酸化位点分别是Ser120/Ser121和Ser174。一个包含I-2第67 - 93位残基的25个氨基酸的合成肽,在其对应于Ser86的丝氨酰残基处被CK2或CK1磷酸化,其Vmax较高,Km值与完整蛋白相似(CK2分别为9 μM和7.2 μM,CK1分别为14.2 μM和5.3 μM)。该肽还包含糖原合酶激酶-3(GSK-3)位点(Thr72),无论其相当于Ser86的丝氨酰残基是否先前已被CK2磷酸化,用GSK-3或p34cdc2激酶均未检测到该肽的磷酸化。I-2(67 - 93)的较短衍生物,包含第72 - 93位和第78 - 93位残基,也很容易被CK1和CK2磷酸化,磷酸化效率与亲本肽相似。一个重现Ser120/Ser121周围磷酸接受位点的17肽被CK2磷酸化,但未被CK1检测到磷酸化,其Km值比包含Ser86的相应15肽(78 - 93)高五倍。一个重现Ser174周围磷酸接受位点的15肽(166 - 180)被CK1磷酸化的效率低于包含其主要磷酸化位点的15肽(78 - 93)(Km为280 μM对33 μM)。该肽也很容易被CK2磷酸化,尽管它缺乏CK2的典型共有序列,并且其Ser174在完整的I-2中几乎不受CK2影响。这些数据清楚地证明,具有N端预磷酸化残基的共有序列SerP/ThrP-Xaa-Xaa-Ser/Thr [弗洛托,H.,格雷夫斯,P. R.,王,A.,菲奥尔,C. J.,罗斯克,R. W. & 罗奇,P. J.(1990)《生物化学杂志》265,14264 - 14269;梅焦,F.,佩里奇,J. W.,雷诺兹,E. C. & 平纳,L. A.(1991)《欧洲生物化学学会联合会快报》283,303 - 306] 并非CK1实现高效和高亲和力磷酸化所必需。它们还表明,I-2被CK2或CK1而非GSK3磷酸化的特异性决定因素完全基于磷酸接受位点的局部结构特征,仅受到I-2整体结构的轻微影响。